Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-17

Clinical Trial Update: Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG) [Phase 1]

View source ↗

Summary

A phase 1 clinical trial update shows that Candid Therapeutics is conducting a Phase 1 study of Cizutamig for Generalized Myasthenia Gravis, currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cizutamig

Snippet

Sponsor: Candid Therapeutics | Conditions: Generalized Myasthenia Gravis | Phase 1 | Status: RECRUITING